Company news

Natera, Inc. news in 2024

Natera, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Jury Rules in Favor of Natera in Patent Infringement Lawsuit Against CareDx; Awards $96.3 Million in Damages to Natera in Lost Profits and Past Royalties

January 28, 2024

Nature Medicine Publishes Two Studies Highlighting Signatera’s Clinical Utility in Patients with Gastrointestinal Malignancies

January 24, 2024

Natera Acquires Reproductive Health Assets from Invitae

January 21, 2024

Natera to Present New Data from the CIRCULATE-Japan and BESPOKE CRC Studies at ASCO GI 2024 Supporting Signatera’s Clinical Utility in CRC

January 17, 2024

Natera Provides Update on Ravgen Trial

January 15, 2024

Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues

January 8, 2024

← Newer news releases

Calls in 2024

Decks in 2024